(Q33255102)

24 July 2017

title

Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells (English)

1 reference

24 July 2017

1 reference

8

Hans E Johnsen

1 reference

24 July 2017

Anne K Mylin

1

1 reference

24 July 2017

Thomas Rasmussen

2

1 reference

24 July 2017

Julia S Johansen

3

1 reference

24 July 2017

Lene M Knudsen

4

1 reference

24 July 2017

Peter H Nørgaard

5

1 reference

24 July 2017

Stig Lenhoff

6

1 reference

24 July 2017

Inger M S Dahl

7

1 reference

24 July 2017

Nordic Myeloma Study Group

9

1 reference

24 July 2017

publication date

23 August 2006

1 reference

European Journal of Haematology

24 July 2017

published in

1 reference

24 July 2017

volume

77

1 reference

24 July 2017

issue

5

1 reference

24 July 2017

page(s)

416-424

1 reference

Multiple myeloma: evolving genetic events and host interactions

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Serum YKL-40 and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Early detection and prognosis of ovarian cancer using serum YKL-40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

International staging system for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Long-term culture of human bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2879.X

10.1111/J.0902-4441.2006.T01-1-EJH2879.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference